Article
Fetal hemoglobin induction in azacytidine responders enlightens methylation patterns related to blast clearance in higher-risk MDS and CMML
2024-03-21
Abstract excerpt
<title>Abstract</title> <p>Background As new treatment options for patients with higher-risk myelodysplastic syndromes are emerging, identification of prognostic markers for hypomethylating agent (HMA) treatment and understanding mechanisms of their delayed and short-term responses are essential. Early fetal hemoglobin (HbF) induction has been suggested as a prognostic indicator for decitabine treated patients....
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- a106ccab-48e2-54a2-8ba6-f56a7356167e
- DOI
- 10.21203/rs.3.rs-4096191/v1
